CanSino to conduct Phase III Covid-19 vaccine trial in Saudi Arabia

China-based CanSino Biologics is set to launch a Phase III clinical trial of its Covid-19 vaccine candidate, Ad5-nCOV, in Saudi Arabia soon, said Saudi health ministry spokesman.